Sk Biopharmaceuticals Co Ltd (326030)

Seoul
108,000.00
+1,500.00(+1.41%)
  • Volume:
    837,078
  • Bid/Ask:
    107,500.00/108,000.00
  • Day's Range:
    107,500.00 - 114,500.00

326030 Overview

Prev. Close
106,500
Day's Range
107,500 - 114,500
Revenue
9.92B
Open
108,000
52 wk Range
98,000 - 269,000
EPS
-3,559.65
Volume
837,078
Market Cap
8.34T
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
275,615
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
78,313,250
Next Earnings Date
Jun 02, 2021
What is your sentiment on Sk Biopharmaceuticals Co Ltd?
or
Vote to see community's results!

Sk Biopharmaceuticals Co Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellSellSell
Technical IndicatorsStrong SellStrong SellSellSellSell
SummaryStrong SellStrong SellStrong SellSellSell

Sk Biopharmaceuticals Co Ltd Company Profile

Sk Biopharmaceuticals Co Ltd Company Profile

Employees
0

SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.